CBT

Cabot Corp Materials Miscellaneous Chemical Products Russell 3000
$74.43Close $3.9BMarket cap $57.32 – $92.8852-week range Nov 2, 2026Next report · after the close

Highlights

Cautions

  • Not in an uptrend 3 of 8 trend conditions
  • Lagging the market RS 36 · weaker than 64% of stocks over 12 months
  • Distribution down-day volume 1.6× up-day volume over 50 sessions
  • Earnings shrinking EPS −94% year on year
  • Results soon Nov 2, 2026, in 1 day

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Sep 30, 2025 · filed Aug 4, 2026
Off 12-month high 20%
1wk up 0.9% price change
1mo down 3.2% price change
12-month return up 13% market up 11% · its own 0%
F-score 6 / 9 Mixed
Altman Z 3.41 Low risk
P/E 11.9× price / earnings
PEG — P/E / EPS growth
P/B 2.5× price / book
Earnings yield up 13.7% EBIT / enterprise value
Cheaper than 82% of the market · markedly cheap
Revenue growth down 7% year on year
EPS growth down 94% latest quarter · -69 pts
Sales growth up 6% latest quarter · +10 pts
ROE up 22% return on equity
Free cash margin up 11% $391.0M FCF
D/E 0.55 long-term debt / equity
Net debt / EBITDA 0.8×
Interest cover 8.2×EBIT / interest
Piotroski tests
  • profitability slipped from last year
  • short-term liquidity weakened
  • assets working less efficiently
  • profitable on its assets
  • generating cash from operations
  • profits backed by cash
  • reduced long-term debt
  • no new shares issued
  • gross margin widened

Repair signals

  • Long-term debt down 21% ($1.1B → $0.9B)
  • Gross margin 24.0% → 25.3%

Trade setup

ATR% 2.2% $1.64 a day · 2×ATR $71.15
RS 36 / 99 vs the universe
Trend 3 / 8 trend template
Relative volume 1.8× vs 50-day average
Up/down volume 0.62 50 sessions
Implied move — no option chain · report Nov 2, 2026
Trend template · 3 of 8
  • Price above the 150 and 200-day averages: fails
  • 150-day average above the 200-day: passes
  • 200-day average rising for a month: passes
  • 50-day average above the 150 and 200-day: fails
  • Price above the 50-day average: fails
  • At least 30% above the 52-week low: fails
  • Within 25% of the 52-week high: passes
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Revenue shrinking Revenue fell 7.0% over the year, from $4.0B to $3.7B.
Last reported Aug 3, 2026
Last shock Aug 4, 2026-9% in one session2.6× volumeon results-9% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $3.7B -7% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $2.6B FY2021 · $3.4B FY2022 · $4.3B FY2023 · $3.9B FY2024 · $4.0B FY2025 · $3.7B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $331.0M -13% on FY2024
-$250M $0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$238.0M FY2021 · $250.0M FY2022 · $209.0M FY2023 · $445.0M FY2024 · $380.0M FY2025 · $331.0M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $391.0M -13% on FY2024
-$200M $0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $177.0M FY2021 · $62.0M FY2022 · -$111.0M FY2023 · $351.0M FY2024 · $451.0M FY2025 · $391.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 25%
  • Net 9%
  • Free cash 11%
-10% 0% 50% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 19% · Net -9% · Free cash 7% FY2021 · Gross 23% · Net 7% · Free cash 2% FY2022 · Gross 20% · Net 5% · Free cash -3% FY2023 · Gross 21% · Net 11% · Free cash 9% FY2024 · Gross 24% · Net 10% · Free cash 11% FY2025 · Gross 25% · Net 9% · Free cash 11%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $598.0M net debt
  • Cash
  • Long-term debt
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $151.0M · Long-term debt $1.1B FY2021 · Cash $168.0M · Long-term debt $717.0M FY2022 · Cash $206.0M · Long-term debt $1.1B FY2023 · Cash $238.0M · Long-term debt $1.1B FY2024 · Cash $223.0M · Long-term debt $1.1B FY2025 · Cash $258.0M · Long-term debt $856.0M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 52.84m -6.4% since FY2020
56.73m 52.84m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 56.47m FY2021 · 56.73m FY2022 · 56.25m FY2023 · 55.24m FY2024 · 54.30m FY2025 · 52.84m
  FY2020Sep 30, 2020 FY2021Sep 30, 2021 FY2022Sep 30, 2022 FY2023Sep 30, 2023 FY2024Sep 30, 2024 FY2025Sep 30, 2025
Revenue $2.6B $3.4B $4.3B $3.9B $4.0B $3.7B
Gross margin 19% 23% 20% 21% 24% 25%
Operating income $21.0M $454.0M $389.0M $526.0M $614.0M $621.0M
Net income -$238.0M $250.0M $209.0M $445.0M $380.0M $331.0M
Net margin -9% 7% 5% 11% 10% 9%
Earnings per share -$4.20 $4.40 $3.67 $7.88 $6.82 $6.11
Free cash flow $177.0M $62.0M -$111.0M $351.0M $451.0M $391.0M
Free cash margin 7% 2% -3% 9% 11% 11%
Cash $151.0M $168.0M $206.0M $238.0M $223.0M $258.0M
Long-term debt $1.1B $717.0M $1.1B $1.1B $1.1B $856.0M
Shareholders' equity $691.0M $947.0M $898.0M $1.3B $1.4B $1.6B
Shares outstanding 56.47m 56.73m 56.25m 55.24m 54.30m 52.84m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 4, 2026 Quarterly ↗ Jun 30, 2026 35d
May 6, 2026 Quarterly ↗ Mar 31, 2026 36d
Feb 4, 2026 Quarterly ↗ Dec 31, 2025 35d
Nov 24, 2025 Annual ↗ Sep 30, 2025 55d
Aug 5, 2025 Quarterly ↗ Jun 30, 2025 36d
May 7, 2025 Quarterly ↗ Mar 31, 2025 37d
Feb 6, 2025 Quarterly ↗ Dec 31, 2024 37d
Nov 20, 2024 Annual ↗ Sep 30, 2024 51d
Aug 6, 2024 Quarterly ↗ Jun 30, 2024 37d
May 9, 2024 Quarterly ↗ Mar 31, 2024 39d
Feb 8, 2024 Quarterly ↗ Dec 31, 2023 39d
Nov 22, 2023 Annual ↗ Sep 30, 2023 53d

Current reports